Comments
The National Pharmaceuticals Pricing Authority (NPPA) last week fixed an upper cap on 17 formulation-based bulk drugs.
The drugs listed in the order included Ciprofloxacin hydrochloride, Sulfasalazine, Promethazine, Prednisolone, Metronidazaloe, Promethazine and Carbamazepine.
The manufacturers of these drugs having a maximum retail price higher than the ceiling price specified in the notification dated April 2, 2014, should revise the maximum retail price to an amount not exceeding the ceiling price plus local taxes in line with the Drug Price Control Order, 2013, the Authority said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.